Introduction: Continuous fetal monitoring is used to objectively record the fetal
| INTRODUC TI ON
Antepartum fetal monitoring aims to reduce perinatal mortality and morbidity rates by detecting signs of fetal compromise such as changes in fetal growth, fetoplacental Doppler waveforms, fetal movements or fetal heart rate (FHR).
1 However, many currently employed forms of fetal monitoring do not significantly reduce perinatal mortality or morbidity, especially in women who have a low risk of complications. [2] [3] [4] One exception may be computerized analysis of the FHR trace; a meta-analysis of two trials including 469 participants found a significantly reduced relative risk of perinatal mortality (0.20, 95% confidence interval (CI) 0.04-0.88) compared with manual interpretation of the FHR trace. 2 A further criticism of current fetal monitoring methods is that they do not provide a longitudinal or objective view of fetal wellbeing and may not be sufficiently sensitive to detect signs of fetal compromise. 5 Consequently, there has been increased interest in application of computerized analysis of the cardiotocograph (CTG) for extended periods.
Continuous fetal monitoring (CFM) describes technologies which
can provide an objective view of fetal wellbeing and could be practically used over long periods of time. A systematic review of five studies including a total of 105 participants found a paucity of data about professionals' and womens' experiences of CFM. 6 This review identified four main themes: practical limitations of the device, negative emotions, positive perceptions and device implementation. In these studies, CFM had high levels of participant satisfaction and was preferred to intermittent CTG. In addition to these studies of acceptability, recent studies have examined the feasibility of using CFM to measure components of the fetal ECG (fECG) 7, 8 and to determine factors (including gestation, 9 maternal body mass index [BMI], 9 uterine contractions, 10 diurnal variation and fetal gender 11, 12 ) which affect FHR parameters and the quality of the CFM recording.
In a questionnaire study of 125 clinicians, 45% of respondents felt that CFM would be beneficial. 13 However, 64.3% of clinicians were concerned that CFM could increase levels of maternal anxiety and only 23.6% of clinicians felt that CFM would provide pregnant women with a sense of reassurance. Importantly, clinicians' concerns and women's experiences of CFM in combination with the technical feasibility of specific techniques of CFM are likely to impact upon the adoption of this novel technology into antenatal care. This study was conducted to evaluate the technical feasibility of CFM for extended periods and explore maternal experience in the same women. This study was not developed to determine the prognostic value of CFM in these participants, rather this study sought to address clinicians' concerns that CFM for extended periods would be associated with increased maternal anxiety.
| MATERIAL AND ME THODS
This study utilized a mixed-methods approach; by combining qualitative and quantitative methodologies we hoped to be able to increase the accuracy and scope of the research. 14 In accordance with the "5 Ps" framework for mixed methods research, this study was conducted within a pragmatist paradigm.
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This study was a single center cohort study, potential partici- [16] [17] [18] Continuous fetal monitoring was performed using a porta- Participants returned to the research clinic the following day and fECG recordings were downloaded using the Monica VS software (Monica Healthcare Ltd). All fECG traces were reviewed by a consultant obstetrician (A.H., E.J.) for clinically significant abnormalities.
Following monitoring, women were asked to complete a second questionnaire booklet containing PSA, GAD-2, STAI and an acceptability questionnaire, which was adapted from a previously validated questionnaire. 19 Data from the questionnaire booklets were extracted into Microsoft EXCEL 2010 (Microsoft, Redmond, WA, USA).
Fetal electrocardiogram recordings were exported from the device software as both a Microsoft EXCEL spreadsheet, with recording parameters broken down into 0.25-second epochs and as
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an automated analysis table containing recording quality (%) of maternal heart rate (MHR) and FHR and interval analysis of the fECG as were calculated using 0.25-second epochs for which a recording was present.
| Statistical analyses
All raw data were reported as frequencies or the median (range).
Anxiety scores were analyzed using Wilcoxon matched pairs test.
All statistical and graphical analyses were performed using STATA version 14 (STATACorp, College Station, TX, USA) and GraphPad PRISM 7.0 (GraphPad Software, La Jolla, CA, USA). A P < .05 was considered statistically significant. Sample size was planned to be a minimum of 20 participants which had 80% statistical power to detect a 20% difference in PSA (α = 0.05). There was no formal power calculation for the qualitative component.
| Semi-structured interviews and qualitative analysis
Following monitoring, participants were asked to partake in a oneto-one semi-structured interview. All interviews were conducted by A.C., S.T. or L.S. in a quiet room using a topic guide which focused on five main areas: defining acceptability, practicalities of the device, the impact of the device on the participant before and after CFM, and the potential clinical implementation of the device. All interviews were audio-recorded and transcribed verbatim. Identifiable information was removed and each participant was assigned a pseudonym. Transcripts were verified to check for transcription errors.
Braun and Clarke's 6-step approach to inductive thematic analysis was followed. 21 Transcripts were subjected to line-by-line coding through iterative reading and re-reading. NVivo (Version 11; QSR International, Doncaster, Vic., Australia) was used to record, analyze and visualize themes. Peer debriefing was employed to ensure validity in themes between A.C., P.A., H.R. and A.H.). 
| Ethical approval

| RE SULTS
| Quantitative data analysis
Twenty-two women agreed to participate in the study; participant demographics are shown in Table 1 . Participant flow is shown in Figure 1 . There was no statistically significant difference in the anxiety scores before or after using the CFM device ( Figure 3A-D) . The PSA showed a trend towards reduction (P = 0.07). The majority of women in this study did not have a preference for CFM using the AN24 device or traditional intermittent CTG, with 30% stating a preference for the AN24 device. This was lower than previous reports ( Figure 3E ).
In all, 80% of the respondents found the device comfortable, although 55% reported irritation with skin electrodes. The majority of respondents felt that the device did not affect their daily living activities and the majority were satisfied with their experience of CFM (Table 3 ). There was a wide range of responses concerning whether the device altered perception of fetal movements and whether participants enjoyed wearing the device; the largest group neither agreed nor disagreed with these statements. The majority of respondents felt that they could put the device on correctly without supervision and all respondents indicated that they would wear the device if advised to do so by a professional. A significant proportion (70%) of respondents felt that improvements could be made to the device, such as: shorter wires, a means of wearing the device that was not around the neck, audible feedback to hear the heartbeat and a smaller box.
Thirteen women agreed to participate in the semi-structured interview ( Figure 1 
| Reassurance and anxiety
The majority of participants in the study found the Monica AN24 to be reassuring; although there were subtle differences as to why women were reassured, this was most frequently expressed as "peace of mind." On the other hand, some participants' anxiety increased as a result of using the Monica AN24, either through concerns that it had detected an abnormality or that they had disturbed the machine and affected the recording quality. For some women, the device was a "double-edged sword," having aspects of both reassurance and anxiety:
It's great to know that the baby's alright, but when the baby's not alright is that going to bring more anxiety and more stress, you know and make that situation even worse.
A number of participants reported the expectations from professionals and members of the public that using Monica AN24 would increase their anxiety:
A lot of people said to me, "Oh does it not make you anxious wearing that?" You know, knowing that it's on but actually I think it, it helps you calm down because you know that, that during that period of time that it's on you're being monitored.
The experience of using the device was also affected by women's pre- 
| The physical device
The second theme summarizes the physical impact that the device had on the experience of participants in this study. Each woman had different physical experiences of wearing the device. The majority of women compared the device favorably to conventional monitoring, valuing the freedom to mobilize and the ability to record fetal wellbeing during normal activities. In some cases some small negative impacts were reported: 
In the interviews, some women highlighted specific issues with the design of the device such as the length of the wires and lanyard:
I was trying to find something to wear where you can't see all the wires 'cos obviously you don't want people asking why you're wearing lots of wires.
(Lisa)
Participants reported they took measures to limit the impact of these problems by tucking wires into their clothing. Some interviewees suggested how to improve the device for example:
I think it would be better if it was wireless. (Hannah)
Although the physical aspects of the device could cause discomfort, women prioritized the reassurance it gave them:
It'd probably get really irritating then, but knowing the benefit it's giving me, there's no question. It wouldn't even be a concern.
(Emma) 
| D ISCUSS I ON
This study demonstrates that CFM for extended periods using a Monica AN24 monitor is feasible and does not have a significant adverse impact upon a mother's experience or anxiety. Importantly, the proportion of successful traces and the proportion of FHR trace recorded are similar to published data (69% vs 73.1%). 10 In addition, the lack of a relation between the quality of FHR trace and maternal BMI, and a weakly positive relation with gestation have also been consistently seen. 8, 9 This suggests that the technical performance of CFM using the Monica AN24
is consistent between study populations. As well as the quantitative measurements, the qualitative data obtained was consistent with a meta-analysis of five published studies, 6 identifying practical limitations of the device, high levels of satisfaction and maternal reassurance, but anxiety as to whether the FHR trace was normal.
Another feature in common with other studies was technical difficulties, meaning that CFM was not successful in all cases, as with other reports this improved with practical experience of the device.
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However, some technical aspects (most notably the physical characteristics of the device) negatively impacted upon women's experience, with a lower proportion expressing a preference for the Monica AN24 compared to conventional CTG than in other studies.
22,23
Therefore, technical developments, specifically to improve the detection of the FHR trace, are required to improve the reliability of the device. Other improvements, such as incorporation of wireless technology are required to improve its usability and women's experience.
This study was strengthened by the mixed methods approach, which gives a holistic evaluation of the technical performance of the device and a detailed view of the impact and experience of wearing the Monica AN24 device. Furthermore, the use of validated anxiety scores allows the findings to be compared with other populations. However, the study is limited by recruiting from a single high-risk clinic in a tertiary maternity unit and by the sample size (although this was comparable to similar cohorts).
Although the sample size for qualitative interviews was small (n = 13), the absence of novel themes arising from the interviews indicated that data saturation had been reached. This is consistent with the findings of Guest et al, 25 who found that data saturation monitoring. Participants also suggested potential areas for technological development of CFM, in particular real-time monitoring and feedback to women that their baby is well.
There is growing interest in using CFM to interpret features of the fECG to either detect cardiac rhythm abnormalities or identify fetal compromise. 7, 8, 12 Given that CFM can record the fECG with adequate quality for interpretation in a large number of cases, the interest in this methodology is likely to increase. However, in addition to technological developments, studies need to consider how normal or deviations from normal are defined and how the potential relation with pregnancy outcome is explored. For example, decelerations, which are non-reassuring or abnormal features on intrapartum FHR traces, were evident in all antepartum FHR traces in this study despite all participants' pregnancies having no evidence of fetal compromise. Consequently, prognostic accuracy studies of CFM should be performed where the recording is not revealed, so that fECG features can be accurately correlated to fetal outcome. One such study found that a single episode of STV <4 ms had a positive predictive value for fetal compromise of 39%, which rose to 80% if there were three episodes of STV < 4 ms. 12 In addition, studies of CFM should focus on populations most likely to benefit such as women with suspected fetal compromise (eg, small-for-gestational-age infants and reduced fetal movements).
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